Fewer PSA Tests May Benefit Older, Low-Risk Prostate Cancer Survivors, Study Says

Fewer PSA Tests May Benefit Older, Low-Risk Prostate Cancer Survivors, Study Says
A new study suggests that older patients who survived prostate cancer with a low risk of recurrence could benefit from fewer prostate cancer antigen (PSA) tests, as they are more likely to experience the harmful effects of PSA monitoring that could outweigh the advantages. The study, “Individualizing PSA Monitoring Among Older Prostate Cancer Survivors,” was published in the Journal of General Internal Medicine.
Subscribe or to access all post and page content.